FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Cipla Lanthanum Carbonate chewable tablets Recall

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx…

Cipla USA, Inc. · Warren, NJ

Risk level
Class II
Reported by FDA
Dec 17, 2025
Recall ID
D-0217-2026
Check your lot numberHow we source this data

Summary

Cipla recalled Lanthanum Carbonate chewable tablets starting Oct 24, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0217-2026 on Dec 17, 2025. Reason: Failed stability specifications: Out of specification for hardness test. Status: Ongoing.

Why it was recalled

Failed stability specifications: Out of specification for hardness test

Product description

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.

Lot numbers, UPCs & expiration codes

lot# NB240315, exp 12/31/2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0217-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 24, 2025
FDA report date
Dec 17, 2025
Quantity
1180 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Cipla USA, Inc.

Original FDA data

Every field from FDA enforcement report D-0217-2026, exactly as published.

Show all FDA fields
City
Warren
State
NJ
Status
Ongoing
Country
United States
Event ID
97855
Address
10 Independence Blvd
Code information
lot# NB240315, exp 12/31/2025
Postal code
07059-2730
Report date
Dec 17, 2025
Product type
Drugs
Recall number
D-0217-2026
Classification
Class II
Recalling firm
Cipla USA, Inc.
Product quantity
1180 boxes
Reason for recall
Failed stability specifications: Out of specification for hardness test
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 24, 2025
Center classification date
Dec 5, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0217-2026, published Dec 17, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls